Under hypoxic conditions, interleukin-6(IL-6) produced by cancer cells induces the activation of Schwann cells and triggers the development of PNI [70], which is also accompanied by the activation of a series of hypoxia-associated signaling pathways. Here, IL6 is linked to cancer.